	US 12,409,129 B2
	Skin care composition
Daniel Richter, Niederfrohna (DE); Jennifer Huepeden, Hamburg (DE); Joern Hendrik Reuter, Henstedt-Ulzburg (DE); Heike Foelster, Hamburg (DE); Bernhard Felten, Pinneberg (DE); Jane Djamil, Hamburg (DE); Peter Steidle, Hamburg (DE); Petra Schoendienst, Tornesch (DE); Tina Hamann, Brodersby-Goltoft (DE); Stefan Gallinat, Wedel (DE); Willy Verheyen, Vosselaar (BE); Joäo Pedro Quintão Reis Pereira De Lima, Antwerp (BE); and Bernhard Felix Paetzold, Berchem (BE)
Assigned to BEIERSDORF AG, Hamburg (DE); and S-BIOMEDIC, Beerse (BE)
Appl. No. 17/754,433
Filed by BEIERSDORF AG, Hamburg (DE); and S-BIOMEDIC, Beerse (BE)
PCT Filed Dec. 18, 2019, PCT No. PCT/EP2019/085884 § 371(c)(1), (2) Date Apr. 1, 2022, PCT Pub. No. WO2021/063532, PCT Pub. Date Apr. 8, 2021.
Claims priority of application No. 19201259 (EP), filed on Oct. 3, 2019.
Prior Publication US 2023/0240975 A1, Aug. 3, 2023
Int. Cl. A61K 8/99 (2017.01); A61K 8/34 (2006.01); A61Q 19/00 (2006.01)

CPC A61K 8/99 (2013.01) [A61K 8/34 (2013.01); A61K 8/345 (2013.01); A61Q 19/00 (2013.01); A61K 2800/524 (2013.01)]

20 Claims

1. A skin care composition, wherein the composition is suitable for topical application to skin and comprises:

(a) lyophilized and/or spray dried live bacteria of at least one cutibacterium acnes (C. acnes) single-locus sequence typing (SLST) type C3 strain and/or at least one C. acnes SLST type K8 strain; and

(b) one or more of from 0.05% to 0.5% (w/w) of phenoxyethanol, from 0.05% to 5.0% (w/w) of caprylyl glycol, from 0.05% to 5.0% (w/w) of methylpropanediol as preservative.